{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct02537470",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct02537470",
  "name": "Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes",
  "aliases": [
    "NCT02537470"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 191 participants.",
  "summary_technical": "Registry record NCT02537470. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2016-08 (actual). Results not posted.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT02537470",
      "normalized_value": "NCT02537470",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "diabetes-and-metabolic-disease"
      ],
      "system": [
        "metabolism"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; randomized; quadruple masking; primary purpose treatment",
    "drug_phase": "2",
    "registry_statuses": [
      {
        "status": "COMPLETED",
        "snapshot": "cardio:ctgov-nct02537470-2018-01-18"
      }
    ],
    "start_date": {
      "date": "2015-07",
      "type": null,
      "snapshot": "cardio:ctgov-nct02537470-2018-01-18"
    },
    "primary_completion_date": {
      "date": "2016-08",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct02537470-2018-01-18"
    },
    "completion_date": {
      "date": "2016-08",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct02537470-2018-01-18"
    },
    "results_first_posted": null,
    "countries": [
      {
        "code": "US",
        "snapshot": "cardio:ctgov-nct02537470-2018-01-18"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 191,
        "basis": "enrolled",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct02537470-2018-01-18"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Acronym",
        "value": "BRID",
        "locator": "protocolSection.identificationModule.acronym"
      },
      {
        "label": "Condition",
        "value": "Type 2 Diabetes Mellitus",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Condition",
        "value": "Diabetes Mellitus, Type 2",
        "locator": "protocolSection.conditionsModule.conditions[1]"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Biphasic Remogliflozin Etabonate",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Intervention (Other)",
        "value": "Placebo",
        "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
      },
      {
        "label": "Lead sponsor",
        "value": "BHV Pharma",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      },
      {
        "label": "Collaborator",
        "value": "Integrium",
        "locator": "protocolSection.sponsorCollaboratorsModule.collaborators[0].name"
      },
      {
        "label": "Collaborator class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.collaborators[0].class"
      }
    ]
  },
  "content_digest": "51f40b7e94fdc8fae9f46e363b5b579fe631ab2f5a538492f9b8efce335838e8",
  "review": {
    "content_digest": "51f40b7e94fdc8fae9f46e363b5b579fe631ab2f5a538492f9b8efce335838e8",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:type-2-diabetes",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02537470-2018-01-18",
          "locator": "derivedSection.conditionBrowseModule.meshes[0].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "sponsored_by",
        "label": "Registry lists this organization as a collaborator",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:org-integrium",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02537470-2018-01-18",
          "locator": "protocolSection.sponsorCollaboratorsModule.collaborators[0].name"
        },
        "primary": false,
        "role": "collaborator",
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct02537470/",
  "context_path": "api/v1/context/cardio--ct-nct02537470.md"
}
